NCT07587515 Phase 1b/2a Study of EYC-0305 in Patients With Neovascular Age-related Macular Degeneration Status RECRUITING Phase PHASE1/PHASE2
NCT07567898 Effectiveness of Multidisciplinary Protocolised Interventions on IVT Non-adherence Rates Status NOT_YET_RECRUITING Phase NA
NCT07557121 Safety and Efficacy of AIV007 Periocular Injection in Patients With Neovascular Age-Related Macular Degeneration Status NOT_YET_RECRUITING Phase PHASE2
NCT07501052 Study of the SCD411 Prefilled Syringe for Treating Adults With Wet Age-Related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema, or Diabetic Retinopathy Status NOT_YET_RECRUITING Phase PHASE2
NCT07484074 A Phase 1b Study to Assess the Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of Intravitreal OLN324 Status COMPLETED Phase PHASE1
NCT07390253 Switch From 2mg Aflibercept to 8mg Aflibercept in Patients With Neovascular Age-related Macular Degeneration Status ACTIVE_NOT_RECRUITING Phase N/A
NCT07328776 AI vs. Physician for Anti-VEGF Decision-Making: An RCT Status NOT_YET_RECRUITING Phase NA
NCT06759597 The Effect of Phacoemulsification on the Macular Changes in Patients with Neovascular Age-related Macular Degeneration Status NOT_YET_RECRUITING Phase N/A
NCT06717139 Recurrence and Predictive OCT Biomarkers in Quiescent Neovascular AMD Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06346600 A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD Status RECRUITING Phase N/A
NCT06184360 Real-world Evaluation of BEOVU (Brolucizumab) Effectiveness and Durability for Treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD) Status COMPLETED Phase N/A
NCT05473715 A Study to Learn How Well Aflibercept Injected Into the Eye Works and How Safe it is When Given in Customized Treatment Intervals in Patients With an Eye Disease Called Neovascular Age-related Macular Degeneration After Start of Treatment Status TERMINATED Phase PHASE4
NCT05439629 Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Macular Degeneration Status COMPLETED Phase PHASE3
NCT05197270 4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration Status RECRUITING Phase PHASE1/PHASE2
NCT04847895 Observation of Treatment Patterns With Lucentis® in Real-life Conditions in All Approved Indications Status COMPLETED Phase N/A
NCT04126317 Safety, Tolerability, and Efficacy of Aflibercept in Patients With Neovascular Age-Related Macular Degeneration Status COMPLETED Phase PHASE2